Diabetes Care
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ford, E. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ford, E. S.
Social Bookmarking
Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Diabetes Care, Vol 22, Issue 12 1971-1977, Copyright © 1999 by American Diabetes Association

ARTICLES

Body mass index, diabetes, and C-reactive protein among U.S. adults

ES Ford
Division of Nutrition and Physical Activity, Centers for Disease Control and Prevention, Atlanta, Georgia 30341, USA. esf2@cdc.gov

OBJECTIVE: The author examined the relationship between C-reactive protein and BMI and diabetes status among 16,573 participants aged > or = 20 years of the Third National Health and Nutrition Examination Survey (1988-1994). RESEARCH DESIGN AND METHODS: The study had a cross-sectional design. RESULTS: Geometric mean concentrations of C-reactive protein were lowest among individuals with a BMI < 18.5 kg/m2 and increased with increasing BMI categories. Restricting the analysis to participants without various medical conditions did not change the relation. After adjusting for age, sex, race or ethnicity, and education, using logistic regression analysis, odds ratios for an elevated C-reactive protein concentration (> or = 85th percentile of the sex-specific C-reactive protein concentration distribution) among participants with a BMI of 25 to < 30, 30 to < 35, 35 to < 40, and > or = 40 kg/m2 were 1.51 (95% CI 1.23-1.86), 3.19 (2.60-3.91), 6.11 (4.67-7.98), and 9.30 (6.43-13.46), respectively, compared with participants with a BMI < 25 kg/m2. C-reactive protein concentrations were lowest among those individuals without diabetes or with impaired fasting glucose and highest among those with newly or previously diagnosed diabetes. Compared with participants with a normal fasting glucose, participants with impaired fasting glucose, newly diagnosed diabetes, and previously diagnosed diabetes had 0.99 (0.72-1.37), 1.84 (1.25-2.71), and 1.59 (1.25-2.01) odds of having an elevated C-reactive protein concentration after adjustment for age, sex, race or ethnicity, education, and BMI. CONCLUSIONS: These results confirm cross-sectional findings from previous studies that show elevated C-reactive protein concentrations among individuals who are obese or have diabetes. The implications of these findings, however, remain unclear.
Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 Diabetes CareHome page
B. V. Howard, L. Best, A. Comuzzie, S. O. E. Ebbesson, S. E. Epstein, R. R. Fabsitz, Wm. J. Howard, A. Silverman, H. Wang, J. Zhu, et al.
C-Reactive Protein, Insulin Resistance, and Metabolic Syndrome in a Population With a High Burden of Subclinical Infection: Insights from the Genetics of Coronary Artery Disease in Alaska Natives (GOCADAN) study
Diabetes Care, December 1, 2008; 31(12): 2312 - 2314.
[Abstract] [Full Text] [PDF]

Home page
 Health Educ ResHome page
D. Thompson, T. Baranowski, K. Cullen, K. Watson, A. Canada, R. Bhatt, Y. Liu, and I. Zakeri
Food, Fun and Fitness Internet program for girls: influencing log-on rate
Health Educ. Res., April 1, 2008; 23(2): 228 - 237.
[Abstract] [Full Text] [PDF]

Home page
 Ann Fam MedHome page
D. E. King, A. G. Mainous III, B. M. Egan, R. F. Woolson, and M. E. Geesey
Effect of Psyllium Fiber Supplementation on C-Reactive Protein: The Trial to Reduce Inflammatory Markers (TRIM)
Ann. Fam. Med, March 1, 2008; 6(2): 100 - 106.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Clin. Nutr.Home page
E. T Aasheim, D. Hofso, J. Hjelmesaeth, K. I Birkeland, and T. Bohmer
Vitamin status in morbidly obese patients: a cross-sectional study
Am. J. Clinical Nutrition, February 1, 2008; 87(2): 362 - 369.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
Y.-X. Meng, E. S. Ford, C. Li, A. Quarshie, A. M. Al-Mahmoud, W. Giles, G. H. Gibbons, and G. Strayhorn
Association of C-Reactive Protein with Surrogate Measures of Insulin Resistance among Nondiabetic US Adults: Findings from National Health and Nutrition Examination Survey 1999 2002
Clin. Chem., December 1, 2007; 53(12): 2152 - 2159.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
B. Memoli, A. Procino, P. Calabro, P. Esposito, G. Grandaliano, G. Pertosa, M. D. Prete, M. Andreucci, S. D. Lillo, G. Ferulano, et al.
Inflammation may modulate IL-6 and C-reactive protein gene expression in the adipose tissue: the role of IL-6 cell membrane receptor
Am J Physiol Endocrinol Metab, October 1, 2007; 293(4): E1030 - E1035.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
A. Muscari, S. Antonelli, G. Bianchi, G. Cavrini, S. Dapporto, A. Ligabue, C. Ludovico, D. Magalotti, G. Poggiopollini, M. Zoli, et al.
Serum C3 Is a Stronger Inflammatory Marker of Insulin Resistance Than C-Reactive Protein, Leukocyte Count, and Erythrocyte Sedimentation Rate: Comparison study in an elderly population
Diabetes Care, September 1, 2007; 30(9): 2362 - 2368.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
J. Bleys, A. Navas-Acien, and E. Guallar
Serum Selenium and Diabetes in U.S. Adults
Diabetes Care, April 1, 2007; 30(4): 829 - 834.
[Abstract] [Full Text] [PDF]

Home page
 Arch Intern MedHome page
D. E. King, B. M. Egan, R. F. Woolson, A. G. Mainous III, Y. Al-Solaiman, and A. Jesri
Effect of a High-Fiber Diet vs a Fiber-Supplemented Diet on C-Reactive Protein Level
Arch Intern Med, March 12, 2007; 167(5): 502 - 506.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
A. Dehghan, I. Kardys, M. P.M. de Maat, A. G. Uitterlinden, E. J.G. Sijbrands, A. H. Bootsma, T. Stijnen, A. Hofman, M. T. Schram, and J. C.M. Witteman
Genetic Variation, C-Reactive Protein Levels, and Incidence of Diabetes
Diabetes, March 1, 2007; 56(3): 872 - 878.
[Abstract] [Full Text] [PDF]

Home page
 Clin. DiabetesHome page
D. M. Capuzzi and J. S. Freeman
C-Reactive Protein and Cardiovascular Risk in the Metabolic Syndrome and Type 2 Diabetes: Controversy and Challenge
Clin. Diabetes, January 1, 2007; 25(1): 16 - 22.
[Abstract] [Full Text] [PDF]

Home page
 Arch Intern MedHome page
S. Dublin, B. French, N. L. Glazer, K. L. Wiggins, T. Lumley, B. M. Psaty, N. L. Smith, and S. R. Heckbert
Risk of New-Onset Atrial Fibrillation in Relation to Body Mass Index
Arch Intern Med, November 27, 2006; 166(21): 2322 - 2328.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
M. K. Figaro, S. B. Kritchevsky, H. E. Resnick, R. I. Shorr, J. Butler, A. Shintani, B. W. Penninx, E. M. Simonsick, B. H. Goodpaster, A. B. Newman, et al.
Diabetes, Inflammation, and Functional Decline in Older Adults: Findings from the Health, Aging and Body Composition (ABC) study.
Diabetes Care, September 1, 2006; 29(9): 2039 - 2045.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
N. de Rekeneire, R. Peila, J. Ding, L. H. Colbert, M. Visser, R. I. Shorr, S. B. Kritchevsky, L. H. Kuller, E. S. Strotmeyer, A. V. Schwartz, et al.
Diabetes, Hyperglycemia, and Inflammation in Older Individuals: The Health, Aging and Body Composition study
Diabetes Care, August 1, 2006; 29(8): 1902 - 1908.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
A. Lopez-Bermejo, J. Khosravi, J. M. Fernandez-Real, V. Hwa, K. L. Pratt, R. Casamitjana, M. M. Garcia-Gil, R. G. Rosenfeld, and W. Ricart
Insulin Resistance Is Associated With Increased Serum Concentration of IGF-Binding Protein-Related Protein 1 (IGFBP-rP1/MAC25).
Diabetes, August 1, 2006; 55(8): 2333 - 2339.
[Abstract] [Full Text] [PDF]

Home page
 Eur J EndocrinolHome page
D M Wunder, M Yared, N A Bersinger, D Widmer, R Kretschmer, and M H Birkhauser
Serum leptin and C-reactive protein levels in the physiological spontaneous menstrual cycle in reproductive age women.
Eur. J. Endocrinol., July 1, 2006; 155(1): 137 - 142.
[Abstract] [Full Text] [PDF]

Home page
 J BiochemHome page
O. Zschenker, T. Illies, and D. Ameis
Overexpression of lysosomal Acid lipase and other proteins in atherosclerosis.
J. Biochem., July 1, 2006; 140(1): 23 - 38.
[Abstract] [Full Text] [PDF]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
J. de Jager, J. M. Dekker, A. Kooy, P. J. Kostense, G. Nijpels, R. J. Heine, L. M. Bouter, and C. D.A. Stehouwer
Endothelial Dysfunction and Low-Grade Inflammation Explain Much of the Excess Cardiovascular Mortality in Individuals With Type 2 Diabetes: The Hoorn Study
Arterioscler. Thromb. Vasc. Biol., May 1, 2006; 26(5): 1086 - 1093.
[Abstract] [Full Text] [PDF]

Home page
 ThoraxHome page
A Sood, E S Ford, and C A Camargo Jr
Association between leptin and asthma in adults
Thorax, April 1, 2006; 61(4): 300 - 305.
[Abstract] [Full Text] [PDF]

Home page
 Eur J EndocrinolHome page
C E Wrede, R Buettner, L C Bollheimer, J Scholmerich, K-D Palitzsch, and C Hellerbrand
Association between serum ferritin and the insulin resistance syndrome in a representative population
Eur. J. Endocrinol., February 1, 2006; 154(2): 333 - 340.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
M. Soinio, J. Marniemi, M. Laakso, S. Lehto, and T. Ronnemaa
High-Sensitivity C-Reactive Protein and Coronary Heart Disease Mortality in Patients With Type 2 Diabetes: A 7-year follow-up study
Diabetes Care, February 1, 2006; 29(2): 329 - 333.
[Abstract] [Full Text] [PDF]

Home page
 Psychosom. Med.Home page
A. Nasermoaddeli, M. Sekine, and S. Kagamimori
Gender Differences in Associations of C-Reactive Protein With Atherosclerotic Risk Factors and Psychosocial Characteristics in Japanese Civil Servants
Psychosom Med, January 1, 2006; 68(1): 58 - 63.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
P. Balagopal, D. George, H. Yarandi, V. Funanage, and E. Bayne
Reversal of Obesity-Related Hypoadiponectinemia by Lifestyle Intervention: A Controlled, Randomized Study in Obese Adolescents
J. Clin. Endocrinol. Metab., November 1, 2005; 90(11): 6192 - 6197.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
Y. Doi, Y. Kiyohara, M. Kubo, T. Ninomiya, Y. Wakugawa, K. Yonemoto, M. Iwase, and M. Iida
Elevated C-Reactive Protein Is a Predictor of the Development of Diabetes in a General Japanese Population: The Hisayama Study
Diabetes Care, October 1, 2005; 28(10): 2497 - 2500.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
S. Devaraj, G. O'Keefe, and I. Jialal
Defining the Proinflammatory Phenotype Using High Sensitive C-Reactive Protein Levels as the Biomarker
J. Clin. Endocrinol. Metab., August 1, 2005; 90(8): 4549 - 4554.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
L. R. Tannock, K. D. O'Brien, R. H. Knopp, B. Retzlaff, B. Fish, M. H. Wener, S. E. Kahn, and A. Chait
Cholesterol Feeding Increases C-Reactive Protein and Serum Amyloid A Levels in Lean Insulin-Sensitive Subjects
Circulation, June 14, 2005; 111(23): 3058 - 3062.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
M. S. O'Neill, A. Veves, A. Zanobetti, J. A. Sarnat, D. R. Gold, P. A. Economides, E. S. Horton, and J. Schwartz
Diabetes Enhances Vulnerability to Particulate Air Pollution-Associated Impairment in Vascular Reactivity and Endothelial Function
Circulation, June 7, 2005; 111(22): 2913 - 2920.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
D. E. King, A. G. Mainous III, B. M. Egan, R. F. Woolson, and M. E. Geesey
Fiber and C-Reactive Protein in Diabetes, Hypertension, and Obesity
Diabetes Care, June 1, 2005; 28(6): 1487 - 1489.
[Full Text] [PDF]

Home page
 J. Am. Coll. Nutr.Home page
D. E. King, A. G. Mainous III, M. E. Geesey, and R. F. Woolson
Dietary Magnesium and C-reactive Protein Levels
J. Am. Coll. Nutr., June 1, 2005; 24(3): 166 - 171.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
A. Festa and S. M. Haffner
Inflammation and Cardiovascular Disease in Patients With Diabetes: Lessons From the Diabetes Control and Complications Trial
Circulation, May 17, 2005; 111(19): 2414 - 2415.
[Full Text] [PDF]

Home page
 CirculationHome page
D. A. Schaumberg, R. J. Glynn, A. J. Jenkins, T. J. Lyons, N. Rifai, J. E. Manson, P. M. Ridker, and D. M. Nathan
Effect of Intensive Glycemic Control on Levels of Markers of Inflammation in Type 1 Diabetes Mellitus in the Diabetes Control and Complications Trial
Circulation, May 17, 2005; 111(19): 2446 - 2453.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
Y. Doi, Y. Kiyohara, M. Kubo, Y. Tanizaki, K. Okubo, T. Ninomiya, M. Iwase, and M. Iida
Relationship Between C-Reactive Protein and Glucose Levels in Community-Dwelling Subjects Without Diabetes: The Hisayama Study
Diabetes Care, May 1, 2005; 28(5): 1211 - 1213.
[Full Text] [PDF]

Home page
 Hum ReprodHome page
D.M. Wunder, R. Kretschmer, and N.A. Bersinger
Concentrations of leptin and C-reactive protein in serum and follicular fluid during assisted reproductive cycles
Hum. Reprod., May 1, 2005; 20(5): 1266 - 1271.
[Abstract] [Full Text] [PDF]

Home page
 JAMAHome page
T. J. Wang, H. Parise, L. M. Sullivan, R. B. D'Agostino Sr, D. Levy, P. A. Wolf, R. S. Vasan, and E. J. Benjamin
Obesity and the Risk of New-Onset Atrial Fibrillation--Reply
JAMA, April 27, 2005; 293(16): 1975 - 1975.
[Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
F. Series, J. Chakir, and D. Boivin
Influence of Weight and Sleep Apnea Status on Immunologic and Structural Features of the Uvula
Am. J. Respir. Crit. Care Med., November 15, 2004; 170(10): 1114 - 1119.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
E.S. Ford, D.M. Mannino, S.C. Redd, A.H. Mokdad, and J.A. Mott
Body mass index and asthma incidence among USA adults
Eur. Respir. J., November 1, 2004; 24(5): 740 - 744.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
K. Kaushal, A. H. Heald, K. W. Siddals, M. S. Sandhu, D. B. Dunger, J. M. Gibson, and N. J. Wareham
The Impact of Abnormalities in IGF and Inflammatory Systems on the Metabolic Syndrome
Diabetes Care, November 1, 2004; 27(11): 2682 - 2688.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
U. A. Ajani, E. S. Ford, and A. H. Mokdad
Prevalence of High C-Reactive Protein in Persons with Serum Lipid Concentrations within Recommended Values
Clin. Chem., September 1, 2004; 50(9): 1618 - 1622.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
D. R. Blake, J. B. Meigs, D. C. Muller, S. S. Najjar, R. Andres, and D. M. Nathan
Impaired Glucose Tolerance, but not Impaired Fasting Glucose, Is Associated With Increased Levels of Coronary Heart Disease Risk Factors: Results From the Baltimore Longitudinal Study on Aging
Diabetes, August 1, 2004; 53(8): 2095 - 2100.
[Abstract] [Full Text] [PDF]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
G. Engstrom, B. Hedblad, L. Stavenow, S. Jonsson, P. Lind, L. Janzon, and F. Lindgarde
Incidence of Obesity-Associated Cardiovascular Disease Is Related to Inflammation-Sensitive Plasma Proteins: A Population-Based Cohort Study
Arterioscler. Thromb. Vasc. Biol., August 1, 2004; 24(8): 1498 - 1502.
[Abstract] [Full Text] [PDF]

Home page
 FASEB J.Home page
F. R. DANESH and Y. S. KANWAR
Modulatory effects of HMG-CoA reductase inhibitors in diabetic microangiopathy
FASEB J, May 1, 2004; 18(7): 805 - 815.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
P. D. Reaven and J. Sacks
Reduced Coronary Artery and Abdominal Aortic Calcification in Hispanics With Type 2 Diabetes
Diabetes Care, May 1, 2004; 27(5): 1115 - 1120.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
E. S. Ford, W. H. Giles, A. H. Mokdad, and G. L. Myers
Distribution and Correlates of C-Reactive Protein Concentrations among Adult US Women
Clin. Chem., March 1, 2004; 50(3): 574 - 581.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
D. S.H. Bell, R. W. Hardy, and R. Desmond
C-Reactive Protein and Glycemic Control in Adults With Diabetes: Response to King et al.
Diabetes Care, February 1, 2004; 27(2): 637 - 638.
[Full Text] [PDF]

Home page
 J. Gerontol. A Biol. Sci. Med. Sci.Home page
S. C. Maty, L. P. Fried, S. Volpato, J. Williamson, F. L. Brancati, and C. S. Blaum
Patterns of Disability Related to Diabetes Mellitus in Older Women
J. Gerontol. A Biol. Sci. Med. Sci., February 1, 2004; 59(2): M148 - 153.
[Abstract] [Full Text] [PDF]

Home page
 QJMHome page
G.M. Hirschfield and M.B. Pepys
C-reactive protein and cardiovascular disease: new insights from an old molecule
QJM, November 1, 2003; 96(11): 793 - 807.
[Abstract] [Full Text] [PDF]

Home page
 The Annals of PharmacotherapyHome page
D. M Cummings, D. E King, and A. G Mainous III
C-Reactive Protein, Antiinflammatory Drugs, and Quality of Life in Diabetes
Ann. Pharmacother., November 1, 2003; 37(11): 1593 - 1597.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
L. Morin-Papunen, K. Rautio, A. Ruokonen, P. Hedberg, M. Puukka, and J. S. Tapanainen
Metformin Reduces Serum C-Reactive Protein Levels in Women with Polycystic Ovary Syndrome
J. Clin. Endocrinol. Metab., October 1, 2003; 88(10): 4649 - 4654.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
S. Nakanishi, K. Yamane, N. Kamei, M. Okubo, and N. Kohno
Elevated C-Reactive Protein Is a Risk Factor for the Development of Type 2 Diabetes in Japanese Americans
Diabetes Care, October 1, 2003; 26(10): 2754 - 2757.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
R. Retnakaran, A. J. G. Hanley, N. Raif, P. W. Connelly, M. Sermer, and B. Zinman
C-Reactive Protein and Gestational Diabetes: The Central Role of Maternal Obesity
J. Clin. Endocrinol. Metab., August 1, 2003; 88(8): 3507 - 3512.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
K. C.B. Tan, N. M.S. Wat, S. C.F. Tam, E. D. Janus, T.H. Lam, and K. S.L. Lam
C-Reactive Protein Predicts the Deterioration of Glycemia in Chinese Subjects With Impaired Glucose Tolerance
Diabetes Care, August 1, 2003; 26(8): 2323 - 2328.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Coll. Nutr.Home page
S. Cho, M. Dietrich, C. J.P. Brown, C. A. Clark, and G. Block
The Effect of Breakfast Type on Total Daily Energy Intake and Body Mass Index: Results from the Third National Health and Nutrition Examination Survey (NHANES III)
J. Am. Coll. Nutr., August 1, 2003; 22(4): 296 - 302.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
T. B. Ledue and N. Rifai
Preanalytic and Analytic Sources of Variations in C-reactive Protein Measurement: Implications for Cardiovascular Disease Risk Assessment
Clin. Chem., August 1, 2003; 49(8): 1258 - 1271.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
G. Engstrom, B. Hedblad, L. Stavenow, P. Lind, L. Janzon, and F. Lindgarde
Inflammation-Sensitive Plasma Proteins Are Associated With Future Weight Gain
Diabetes, August 1, 2003; 52(8): 2097 - 2101.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
M. T. Schram, N. Chaturvedi, C. Schalkwijk, F. Giorgino, P. Ebeling, J. H. Fuller, and C. D. Stehouwer
Vascular Risk Factors and Markers of Endothelial Function as Determinants of Inflammatory Markers in Type 1 Diabetes: The EURODIAB Prospective Complications Study
Diabetes Care, July 1, 2003; 26(7): 2165 - 2173.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
J. M. Fernandez-Real and W. Ricart
Insulin Resistance and Chronic Cardiovascular Inflammatory Syndrome
Endocr. Rev., June 1, 2003; 24(3): 278 - 301.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
P. Dandona, A. Aljada, A. Chaudhuri, and A. Bandyopadhyay
The Potential Influence of Inflammation and Insulin Resistance on the Pathogenesis and Treatment of Atherosclerosis-Related Complications in Type 2 Diabetes
J. Clin. Endocrinol. Metab., June 1, 2003; 88(6): 2422 -